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IntroductionAfter surgery, it is necessary to establish a series of markers that tell us the patient prognosis and allow a prompt action whether it is not favourable. CRP is a tissue aggression marker. Multiple studies incorporate it to see the immune response of the patients after the surgical aggression and then study the degree 
of inflammatory response (7-10). The higher its value, the higher 
the probability of systemic inflammatory response syndrome 
(SIRS). CRP measurement is done just before surgery and in the postoperative days to see its evolution. Whether its values increase 
with time, it is indicative of a greater inflammatory response, and therefore, of a possible complication during recovery.
Open Surgery and Laparoscopic SurgeryWithin the gastrointestinal surgery there are two fundamental 
surgical procedures, open surgery (OS) and laparoscopic surgery 
(LS). Although evidence-based medicine shows that the laparoscopic 
approach is more beneficial for the patient and its recovery [11-
13], there are still some doubts about its use since discrepancies have been obtained in studies to observe the immune response 
of patients [14-16], especially in certain surgical resections or when their performance cannot be carried out by properly trained surgeons. CRP is the usual marker used among others to compare 
both surgical approaches and justify that approach produces a 
lower inflammatory response, and therefore would be the most 
beneficial for the patient recovery. Most studies indicate lower 
 
values of CRP in LS compared to OS in the postoperative days [17- 
20]. Few studies find no significant differences between OS and 
LS groups [21,22], characterized by having a low number of study 
subjects or because the clinical and surgical characteristics (body 
mass index, duration of surgery, blood loss) have differed between the two comparison groups. These facts would indicate that CRP 
is a good marker of the inflammatory response, since its value increases taking into account all the factors of study and is not 
only affected by the surgical approach. In fact, several studies have 
observed there are no significant differences in CRP values when 
comparing OS and LS in patients who have suffered complications 
[4], even comparing patients included in ERAS protocols versus 
standard care protocols [6].
Complications and ERAS ProtocolsCRP use as an early complications marker is increasingly widespread. CRP levels rise after the surgical act observing a peak 
at 48h, after which time its values decrease in patients who do not 
suffer complications. In this way, it is used as a discharge criterion whether the elevation of its values is not observed throughout the 
postoperative period [23]. In addition, CRP measurement is a good 
candidate to observe which ERAS parameters have more influence on the recovery of the patient. Since the application of these 
protocols, countless benefits have been reported [24]. However, its implementation is complex and requires great coordination among 
The Use of C-Reactive Protein (CRP) as a Marker  
of the Surgical Stress in Gastrointestinal Surgery
Ana Belén Martínez Martínez*
Faculty of Health Sciences, University of Zaragoza, Spain
Received: : October 04, 2018;  Received: : October 15, 2018 
*Corresponding author: Ana Belén Martínez Martínez, Faculty of Health Sciences, University of Zaragoza, Zaragoza, Spain, Email: 
 
Abstract
Being able to predict the complications that can arise after a surgical intervention is essential to accelerate the recovery of patients, minimize 
pain or save their lives in the most crucial cases. Different markers of surgical aggression [1-3] have been studied, being to use C-reactive protein 
(CRP) measurement during the postoperative period the current trend to predict the evolution of the patients [4-6]. A brief review of the utility of 
CRP measurement is showed to assess its use as the choice marker of the surgical injury.
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all the health personnel involved. Measures to take through the CRP marker assessment, reducing them to the minimum necessary, 
could help to extend ERAS protocols implementation.
Other Markers
Other markers have been studied for the degree of inflammatory 
response after the surgical act [25]. In addition to CRP, the main 
inflammatory markers studied have been IL-6, cortisol and white 
blood cells (WBC) count [26]. IL-6 seems to show similar results 
to CRP [15,27]. Furthermore, the time of peak response is earlier 
than CRP, between 12 and 24 hours. However, its measurement is not within clinical routine laboratory worldwide, being its use less widespread. Regarding cortisol, it has been reported an early time of 
peak response, from 0 to 4 hours. However, cortisol concentrations have not been associated clearly with the magnitude of the surgical 
injury [28]. The same happens with the WBC. In spite of detecting 
its response peak before than CRP, at 24 hours, the variable range of values obtained does not allow to assess the magnitude of the 
surgical damage and, therefore, of the inflammatory response and 
the possibility of SIRS [29]. Other studies have made measurements of parameters such as alarmines, serum cytokines, alpha defensins 
and TNF- among others in the search for a more specific marker 
[21,30-32]. However, their measurements are more complex and the results obtained do not provide much additional information. CRP values increase according to the magnitude of the surgical trauma, its measurement is simple and is established as routine in most hospitals, being therefore the marker usually chosen.
CRP in the Future
In general, CRP seems to be a good marker of the inflammatory 
response and its use is increasingly widespread. However, there are 
several disadvantages in its use. On the one hand, it is a nonspecific 
inflammatory marker. It would be necessary to work in the search 
of more specific or complementary markers that would orient on the type of complication to appear, or at least, on the degree of complication according to the Clavien Dindo complications scale. 
On the other hand, until roughly 48 hours CRP peak response cannot be clearly detected, being usual to observe high values up 
to 4 days later. Thus, reaction time before a serious complication is reduced. A marker that indicated earlier the beginning of 
a complication would be more appropriate. And finally, there 
is still no standardization on its use. The times in which CRP 
measurements are made depend on the organizational structure of 
each hospital. In general, measurements are made between prior to 
surgery and 72 hours post-surgery, being variable the number and times of measurement. Most studies perform CRP measurements 
preoperatively and in the first, second and third postoperative day. 
Working on a standardization of its use and the establishment of alarm reference values should be a priority task to be used as an early marker of surgical complications and as an indicator of a 
lesser inflammatory process when comparing different techniques or procedures.
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